- Home
- AVDL vs AC Comparison
AVDL vs AC Comparison
Compare AVDL & AC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- AC
- Stock Information
- Founded
- AVDL 2015
- AC 1976
- Country
- AVDL Ireland
- AC United States
- Employees
- AVDL N/A
- AC N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- AC Investment Bankers/Brokers/Service
- Sector
- AVDL Health Care
- AC Finance
- Exchange
- AVDL Nasdaq
- AC Nasdaq
- Market Cap
- AVDL 784.6M
- AC 809.6M
- IPO Year
- AVDL 1996
- AC N/A
- Fundamental
- Price
- AVDL $9.39
- AC $35.80
- Analyst Decision
- AVDL Strong Buy
- AC
- Analyst Count
- AVDL 7
- AC 0
- Target Price
- AVDL $18.86
- AC N/A
- AVG Volume (30 Days)
- AVDL 1.3M
- AC 4.9K
- Earning Date
- AVDL 05-07-2025
- AC 05-08-2025
- Dividend Yield
- AVDL N/A
- AC 6.08%
- EPS Growth
- AVDL N/A
- AC 16.36
- EPS
- AVDL N/A
- AC 1.80
- Revenue
- AVDL $194,450,000.00
- AC $12,293,000.00
- Revenue This Year
- AVDL $50.53
- AC N/A
- Revenue Next Year
- AVDL $32.33
- AC N/A
- P/E Ratio
- AVDL N/A
- AC $20.15
- Revenue Growth
- AVDL 252.64
- AC N/A
- 52 Week Low
- AVDL $6.38
- AC $28.58
- 52 Week High
- AVDL $17.85
- AC $43.85
- Technical
- Relative Strength Index (RSI)
- AVDL 64.66
- AC 53.33
- Support Level
- AVDL $8.55
- AC $34.30
- Resistance Level
- AVDL $9.98
- AC $36.90
- Average True Range (ATR)
- AVDL 0.51
- AC 1.02
- MACD
- AVDL 0.10
- AC 0.13
- Stochastic Oscillator
- AVDL 72.04
- AC 68.57
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
About AC Associated Capital Group Inc.
Associated Capital Group Inc is a diversified global financial services company. It operates in the business of alternative investment management, institutional research services, and cash and other assets through subsidiaries. The activities of its subsidiaries comprise publishing daily research notes and full reports using private market value with a catalyst methodology and also products and customized solutions utilizing private market value with catalyst method of investing.